Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)…15 hours ago
Cureus pembrolizumab-induced colitis and diarrhea in the treatment of sporadic colorectal cancer: a case report Pembrolizumab is an immune checkpoint that blocks programmed cell death receptor-1 (PD-1), a mainstay of cancer treatment. Inhibitor (ICI)…15 hours ago